A micro‐RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas
暂无分享,去创建一个
Patricia Soteropoulos | Jian-Jun Wei | Laura Obijuru | Jian-jun Wei | Peng Lee | J. Laser | Xinmin Zhang | Peng Lee | V. Aris | P. Soteropoulos | K. Mittal | Tongsheng Wang | Virginie Aris | Xinmin Zhang | L. Obijuru | Tongsheng Wang | Jordan Laser | Khush Mittal
[1] Wen-Hsiung Li,et al. Fundamentals of molecular evolution , 1990 .
[2] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[3] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[4] L. Aaltonen,et al. 7q deletion mapping and expression profiling in uterine fibroids , 2005, Oncogene.
[5] U. Fuhrmann,et al. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas. , 1999, The American journal of pathology.
[6] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[7] L. Aaltonen,et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. , 2004, The American journal of pathology.
[8] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. Tuschl,et al. Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.
[10] J. Manson,et al. Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race , 1997, Obstetrics and gynecology.
[11] Jeffrey Shelton,et al. An optimized isolation and labeling platform for accurate microRNA expression profiling. , 2005, RNA.
[12] L. Orozco,et al. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis. , 2000, Nephrologie.
[13] H. Peterson,et al. Hysterectomy in the United States, 1988‐1990 , 1994, Obstetrics and gynecology.
[14] N. Iwai,et al. Assessment of the MicroRNA System in Salt-Sensitive Hypertension , 2005, Hypertension Research.
[15] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[16] M. Perola,et al. Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study. , 2000, Maturitas.
[17] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[19] J. Bullerdiek,et al. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. , 1999, Molecular human reproduction.
[20] S. Weremowicz,et al. HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies , 2003, Genes, chromosomes & cancer.
[21] A. Al-Hendy,et al. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. , 2006, Fertility and sterility.
[22] A. Al-Hendy,et al. Catechol-O-Methyltransferase Polymorphism Is Associated With Increased Uterine Leiomyoma Risk in Different Ethnic Groups , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[23] J. Melamed,et al. Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. , 2006, Human reproduction.
[24] M. Tang,et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. , 2005, Human reproduction.
[25] C. Steiner,et al. Hysterectomy Rates in the United States 1990–1997 , 2002, Obstetrics and gynecology.
[26] C. Croce,et al. The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] Y. Trotsenko,et al. Fundamentals of molecular evolution, 2nd Edition. By Dan Graur and Wen-Hsiung Li, Sinauer Associates, Inc, Sanderland, Massachusetts, 2000, xiv + 481 pp, price £27.95. ISBN 0 87893 266 6 , 2001 .
[28] L. Chiriboga,et al. Spatial differences in biologic activity of large uterine leiomyomata. , 2006, Fertility and sterility.
[29] Hanah Margalit,et al. Clustering and conservation patterns of human microRNAs , 2005, Nucleic acids research.
[30] P. Rogalla,et al. HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality. , 1997, Cancer genetics and cytogenetics.
[31] Dan Graur,et al. Fundamentals of Molecular Evolution, 2nd Edition , 2000 .
[32] P. Cin,et al. Uterine Leiomyomata with t(10;17) Disrupt the Histone Acetyltransferase MORF , 2004, Cancer Research.
[33] K. Hirschhorn,et al. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. , 2000, Cancer genetics and cytogenetics.
[34] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[35] David B Dunson,et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. , 2003, American journal of obstetrics and gynecology.
[36] D. Spiegelman,et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. , 2004, American journal of epidemiology.
[37] C. Morton,et al. Leiomyomata: heritability and cytogenetic studies. , 2001, Human reproduction update.
[38] P. Stolley,et al. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. , 1996, The Journal of reproductive medicine.
[39] C. Croce,et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Common,et al. Pregnancy After Uterine Artery Embolization for Leiomyomata:: The Ontario Multicenter Trial , 2005, Obstetrics and gynecology.
[41] R. Cantor,et al. Cytogenetic abnormalities in uterine myomas are associated with myoma size. , 1998, Molecular human reproduction.
[42] Yuriy Gusev,et al. Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.
[43] D. Dixon,et al. Etiology and pathogenesis of uterine leiomyomas: a review. , 2003, Environmental health perspectives.
[44] E. Miska,et al. MicroRNA functions in animal development and human disease , 2005, Development.
[45] B. Reinhart,et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA , 2000, Nature.
[46] M. Amarzguioui,et al. Approaches for chemically synthesized siRNA and vector‐mediated RNAi , 2005, FEBS letters.
[47] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[48] Isaac Bentwich. Available online , 2005 .
[49] B. Reinhart,et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.
[50] R. Kudo,et al. Familial aggregation of uterine myomas in Japanese women. , 2002, Journal of epidemiology.
[51] D. Wotton,et al. TGIF Inhibits Retinoid Signaling , 2006, Molecular and Cellular Biology.